Podbit · All-In with Chamath, Jason, Sacks & Friedberg
The math is unambiguous: VC funds under $750M average 4.76x DPI versus 2.42x for funds over $1B, and represent 95% of all top-decile performers. Maris's six Section32 funds have averaged ~$400M in size and all landed in the top decile.
Where this was said
At 21:40 · chapter starts 19:09
The sharpest moment in the conversation arrives when Maris raises what he considers Google's obvious strategic play: slash token prices by 80% and watch OpenAI and Anthropic's business models go 'super critical.' If an enterprise can get a basically identical product from Gemini at a fifth of the price, why wouldn't they switch? The panel explores whether OpenAI is burning investor cash Uber-style to grab market share, and whether the public markets will eventually be left holding the bag. Maris is blunt: with approximately $1 trillion in spend commitments and only $60 billion in revenue, OpenAI's IPO math relies on retail and passive funds absorbing valuations that the S&P 500 rules are already being bent to accommodate. [1] — Bill Maris "Google could arbitrarily cut token prices by 80%, making its model functionally identical to OpenAI's at a fraction of the cost — and Maris…" 24:50
The transformation gaming underwent from text-based Zork to photorealistic modern games will happen to AI within the next 5 years, per Maris.
Bill Maris compared today's AI to the Atari command-line era and predicted it would reach PlayStation-equivalent sophistication within 5 years.
Maris founded Calico, invested in Flatiron and New Limit, and remains deeply interested in longevity — but says therapeutic clinical trials are a specialist area he's stepping back from. The real prize is computational biology: simulate a human cell in silico and drug discovery accelerates exponentially.
Bill Maris's Section32 has raised 6 funds averaging ~$400M in size, with all 6 performing in the top decile.
Funds smaller than $750M averaged 4.76x DPI returns versus 2.42x for funds over $1B, according to Bill Maris's analysis.
Sam built Algrow, a SaaS for finding viral content formats, with zero coding experience using ChatGPT and Cursor. Six months later: 10,000 users, $14K/month in revenue.
Sam's first MVP threw an application error on its very first user — and he shipped it anyway. The core idea worked, and that was enough to validate the product and keep users coming back.
Sam joined Discord voice chats, muted himself, and silently screen-shared his product. Users in the chat started tagging him asking what the tool was. No pitch needed — curiosity did the selling.
Most founders post links in Discord and immediately get banned for self-promotion. Sam's approach was the opposite: build rapport, help people with the tool, let word of mouth do the work.
Find where your ICP lives. Listen before building. Validate with DMs and Loom recordings. Build in public with users inside your own Discord server. Turn early adopters into advocates with free access.
Instead of fearing the self-promo ban in large Discord servers, create your own private server for your product. You funnel in ideal customers and build a relationship that email can't replicate.
Algrow helps creators find and replicate viral video formats, starting at $25/month. It analyzes subscriber counts, average views, and trending formats — and can even generate the videos with AI.
After weeks of Sam silently screen-sharing in a Discord server, the server owner — unprompted — made a full YouTube promotional video about Algrow. Sam paid nothing and asked for nothing.
Producer Gus admits Discord never crossed his mind as a customer acquisition channel. Pat connects the insight to a broader lesson: match your distribution channel to where your actual customers live.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.